logo
logo
Sign in

Osteoporosis Drugs Market Segmented by Regions, Types and Applications with Forecast Report from 2021 – 2025

avatar
Viraj Patil

The global Osteoporosis Drugs Market size is expected to value at USD 16.3 billion by 2025. The osteoporosis drug industry is subject to witness a substantial growth due to the rise in elderly population and increase in the occurrence of target diseases like osteoporosis. Global occurrence of osteoporosis along with high demand for drugs in prophylaxis and treatment is propelling the growth of osteoporosis drug market, in the recent years. Globally, the osteoporosis drugs industry is predicted to grow at higher CAGR over next seven years, providing numerous opportunities for market players to invest for research and development in the osteoporosis drugs.

Osteoporosis is a primary cause of reduced bone density inducing the pain with a minor form of injury or trauma. As many as nine million people have been reported suffering from the osteoporosis disease on annual basis across the globe. Such factors are causing frequent osteoporotic conditions every three seconds. Prime victims of the disease are menopausal women. For instance, one out of three women above the age of fifty experiences an osteoporotic fracture. These factors are responsible for the growth of osteoporosis drugs market, thus creating lucrative opportunities for market players, in recent years. Substantial rise in the elderly population in both developed and developing economies across the globe are driving the demand for osteoporosis drugs.

Request a Sample Copy of Osteoporosis Drugs Market Report @ https://www.millioninsights.com/industry-reports/osteoporosis-drug-market/request-sample

Global Osteoporosis Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Branded
  • Bisphosphonates
  • Parathyroid Hormone Therapy
  • Calcitonin
  • Selective Estrogen Inhibitors Modulator(SERM)
  • Rank Ligand Inhibitors
  • Others
  • Generics

The rank ligand inhibitors is considered as one of the faster growing segment in the osteoporosis drug market with substantial revenue generation in the last few years. Increase in preference by healthcare professional due to positive outcomes in patient attributes to the growing popularity of the rank ligand inhibitors segment. The Selective Estrogen Inhibitors Modulator (SERM) segment also witnesses substantial growth owing to the increasing adoption in conjunction with other drugs to impart a synergistic effect.

The key players in the osteoporosis drug industry are Actavis Inc., DePuy Synthes Companies, Zimmer Biomet Holdings, Inc., Stryker Co., Integra LifeSciences Co., Pfizer Inc., and Dr. Reddy’s Laboratory.

Access Osteoporosis Drugs Market Report with TOC @ https://www.millioninsights.com/industry-reports/osteoporosis-drug-market

Osteoporosis Drugs Regional Outlook (Revenue, USD Billion, 2014 - 2025)

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • Japan
  • China
  • India
  • Latin America
  • Mexico
  • Brazil
  • MEA
  • South Africa

Visit Our Blog: https://marketreportsassistance.wordpress.com

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: [email protected]

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184

Email: [email protected]

 

collect
0
avatar
Viraj Patil
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more